Deitrich Richard A, Petersen Dennis, Vasiliou Vasilis
Department of Pharmacology, University of Colorado School of Medicine, University of Colorado, HSC, PO Box 6511, Mail Stop 8303, Aurora, CO 80045, USA.
Novartis Found Symp. 2007;285:23-40; discussion 40-51, 198-9. doi: 10.1002/9780470511848.ch3.
The reduction of acetaldehyde back to ethanol via NAD-linked alcohol dehydrogenase is an important mechanism for keeping acetaldehyde levels low following ethanol ingestion. However, this does not remove acetaldehyde from the body, but just delays its eventual removal. Acetaldehyde is removed from the body primarily by oxidation to acetate via a number of NAD-linked aldehyde dehydrogenase (ALDH) enzymes. There are nineteen known ALDHs in humans, but only a few of them appear to be involved in acetaldehyde oxidation. There are many analogous enzymes in other organisms. Genetic polymorphisms of several ALDHs have been identified in humans that are responsible for several hereditary defects in the metabolism of normal endogenous substrates. The best known ALDH genetic polymorphism is in ALDH2 gene, which encodes a mitochondrial enzyme primarily responsible for the oxidation of the ethanol-derived acetaldehyde. This common polymorphism is known to dominantly inhibit its enzymatic activity resulting in reduced ability to clear acetaldehyde in both homozygote and heterozygote individuals. These individuals are generally protected against alcohol abuse but are susceptible to oesophageal cancer. For those enzymes that are capable of reacting with acetaldehyde, they may do so at the expense of their normal substrates, resulting in abnormal accumulation of these substrates. Examples of this are the aldehydes of the biogenic amines, dopamine, noradrenaline, adrenaline, serotonin and long chain lipid aldehydes such as nonenal. Not all of these enzymes are capable of efficient oxidation of acetaldehyde; however, it is possible that acetaldehyde may function as an inhibitor of these enzymes as well. The aldehydes whose metabolism is interfered with may also serve as inhibitors of ALDHs as well. However, this aspect of aldehyde function has not been extensively studied. A number of other mechanisms for the removal of acetaldehyde exist. For example, reaction of acetaldehyde with protein or nucleic acids is responsible for the disappearance of a small amount of acetaldehyde, but may be responsible for some pathological effects of acetaldehyde. There are a few other enzymes such as aldehyde oxidase, xanthine oxidase, cytochrome P450 oxidase and glyceraldehyde-3-phosphate dehydrogenase that are capable of oxidizing acetaldehyde. However, these enzymes account for only a small fraction of the total activity.
通过与NAD相关的醇脱氢酶将乙醛还原为乙醇是乙醇摄入后保持乙醛水平较低的重要机制。然而,这并不能将乙醛从体内清除,而只是延迟其最终清除。乙醛主要通过多种与NAD相关的醛脱氢酶(ALDH)氧化为乙酸盐从而从体内清除。人类已知有19种ALDH,但其中只有少数似乎参与乙醛氧化。其他生物中也有许多类似的酶。已在人类中鉴定出几种ALDH的基因多态性,它们导致正常内源性底物代谢中的几种遗传性缺陷。最著名的ALDH基因多态性存在于ALDH2基因中,该基因编码一种线粒体酶,主要负责氧化乙醇衍生的乙醛。已知这种常见的多态性会显性抑制其酶活性,导致纯合子和杂合子个体清除乙醛的能力降低。这些个体通常受到酒精滥用的保护,但易患食管癌。对于那些能够与乙醛反应的酶,它们可能会以牺牲其正常底物为代价来进行反应,导致这些底物异常积累。生物胺、多巴胺、去甲肾上腺素、肾上腺素、5-羟色胺的醛以及长链脂质醛如壬醛就是这样的例子。并非所有这些酶都能够有效氧化乙醛;然而,乙醛也有可能作为这些酶的抑制剂。其代谢受到干扰的醛也可能作为ALDH的抑制剂。然而,醛功能的这一方面尚未得到广泛研究。还存在许多其他清除乙醛的机制。例如,乙醛与蛋白质或核酸的反应导致少量乙醛消失,但可能是乙醛某些病理作用的原因。还有一些其他酶,如醛氧化酶、黄嘌呤氧化酶、细胞色素P450氧化酶和3-磷酸甘油醛脱氢酶能够氧化乙醛。然而,这些酶仅占总活性的一小部分。